Pharmozyme Incorporated

Pharmozyme Incorporated is a small biotechnology company based in Sunnyvale, California. The company employs 11 individuals and generates over $10,000 in annual revenue. Pharmozyme specializes in innovative enzyme and protein production for research purposes. They are known for developing a Taq Polymerase product free from background DNA contamination, a significant advancement in the field. Their newest offering is the RNA extraction free EF1 SARS-CoV-2 Detection Kit, which has received CE marking for in vitro diagnostics. Pharmozyme is committed to providing cutting-edge solutions that improve the efficiency and accuracy of research. Their focus on developing novel technologies, such as their contamination-free Taq Polymerase and rapid SARS-CoV-2 detection kit, sets them apart in the market. For more information about Pharmozyme Incorporated and their products, please visit their website at www.pharmozyme.com.